loading
Schlusskurs vom Vortag:
$1.33
Offen:
$1.32
24-Stunden-Volumen:
70,500
Relative Volume:
0.16
Marktkapitalisierung:
$66.33M
Einnahmen:
$96.63M
Nettoeinkommen (Verlust:
$-63.32M
KGV:
-0.911
EPS:
-1.46
Netto-Cashflow:
$-54.55M
1W Leistung:
+5.56%
1M Leistung:
+4.72%
6M Leistung:
-44.35%
1J Leistung:
-45.49%
1-Tages-Spanne:
Value
$1.31
$1.367
1-Wochen-Bereich:
Value
$1.195
$1.367
52-Wochen-Spanne:
Value
$0.931
$3.42

Akoya Biosciences Inc Stock (AKYA) Company Profile

Name
Firmenname
Akoya Biosciences Inc
Name
Telefon
855.896.8401
Name
Adresse
100 CAMPUS DRIVE, MARLBOROUGH
Name
Mitarbeiter
205
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-17
Name
Neueste SEC-Einreichungen
Name
AKYA's Discussions on Twitter

Vergleichen Sie AKYA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
AKYA
Akoya Biosciences Inc
1.33 66.33M 96.63M -63.32M -54.55M -1.46
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
539.74 189.82B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
171.31 49.98B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
87.95 44.00B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
255.59 37.05B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
219.05 16.36B 2.90B 467.20M 306.90M 6.37

Akoya Biosciences Inc Stock (AKYA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-15 Herabstufung Craig Hallum Buy → Hold
2024-08-06 Herabstufung BTIG Research Buy → Neutral
2024-08-06 Herabstufung JP Morgan Overweight → Neutral
2024-08-06 Herabstufung Morgan Stanley Overweight → Equal-Weight
2024-06-21 Eingeleitet Craig Hallum Buy
2023-12-14 Eingeleitet Guggenheim Neutral
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-02-02 Eingeleitet UBS Buy
2022-11-03 Eingeleitet CapitalOne Overweight
2022-10-06 Eingeleitet Stephens Overweight
2022-06-22 Eingeleitet BTIG Research Buy
2022-01-06 Fortgesetzt Piper Sandler Overweight
2021-05-11 Eingeleitet Canaccord Genuity Buy
2021-05-11 Eingeleitet JP Morgan Overweight
2021-05-11 Eingeleitet Morgan Stanley Overweight
2021-05-11 Eingeleitet Piper Sandler Overweight
Alle ansehen

Akoya Biosciences Inc Aktie (AKYA) Neueste Nachrichten

pulisher
Jun 12, 2025

Transcript : Akoya Biosciences, Inc.Special Call - MarketScreener

Jun 12, 2025
pulisher
Jun 10, 2025

Akoya Biosciences, Inc. (NASDAQ:AKYA) Shares Sold by Jane Street Group LLC - Defense World

Jun 10, 2025
pulisher
Jun 04, 2025

Deutsche Bank AG Raises Stock Holdings in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Akoya Biosciences (AKYA) Receives Price Target Cut from Morgan S - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Akoya Biosciences (AKYA) Receives Price Target Cut from Morgan Stanley | AKYA Stock News - GuruFocus

Jun 02, 2025
pulisher
May 31, 2025

Northern Trust Corp Buys 39,799 Shares of Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World

May 31, 2025
pulisher
May 30, 2025

Spatial proteomics Market Worth Observing Growth: Bruker, Akoya Biosciences, PerkinElmer - newstrail.com

May 30, 2025
pulisher
May 29, 2025

Spatiotemporal Omics Market Research Report 2025-2035, Competitive Analysis of Prominent Players10X Genomics, Akoya Biosciences, Bruker, Curio Bioscience, IonPath, MGI, and RareCyteResearchAndMarkets.com - FinancialContent

May 29, 2025
pulisher
May 29, 2025

Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Average Recommendation of “Hold” from Brokerages - Defense World

May 29, 2025
pulisher
May 23, 2025

New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs - Benzinga

May 23, 2025
pulisher
May 23, 2025

Quanterix Merger Drama: 6.9% Holder Fights Board as Rival $1.40 Cash Offer Threatens Deal - Stock Titan

May 23, 2025
pulisher
May 22, 2025

Akoya surges as unsolicited buyout offer risks Quanterix merger - MSN

May 22, 2025
pulisher
May 21, 2025

Akoya Biosciences (AKYA) Soars on New Acquisition Proposal - GuruFocus

May 21, 2025
pulisher
May 21, 2025

An undisclosed buyer agreed to acquire Akoya Biosciences, Inc.. - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

Akoya Biosciences Receives Unsolicited Buyout Offer From Third Party - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

Akoya Biosciences considering unsolicited buyout amidst merger proceedings - Worcester Business Journal

May 21, 2025
pulisher
May 21, 2025

Akoya stock surges as new buyout bid risks Quanterix deal (AKYA) - Seeking Alpha

May 21, 2025
pulisher
May 21, 2025

Akoya Biosciences reviews unsolicited acquisition proposal By Investing.com - Investing.com Nigeria

May 21, 2025
pulisher
May 21, 2025

Akoya Biosciences reviews unsolicited acquisition proposal - Investing.com India

May 21, 2025
pulisher
May 21, 2025

Akoya Biosciences IncOn May 20, Receives Unsolicited Acquisition Proposal At $1.40 Per Share From A Third Party- SEC Filing - marketscreener.com

May 21, 2025
pulisher
May 20, 2025

Akoya Biosciences (NASDAQ:AKYA) Given New $1.08 Price Target at Canaccord Genuity Group - Defense World

May 20, 2025
pulisher
May 20, 2025

Akoya Biosciences Reports Q1 2025 Financial Results - TipRanks

May 20, 2025
pulisher
May 19, 2025

Akoya Biosciences (AKYA) Target Price Reduced by Canaccord | AKY - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Akoya Biosciences (AKYA): Analyst Lowers Price Target | AKYA Sto - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Akoya Biosciences (AKYA): Analyst Lowers Price Target | AKYA Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Akoya Biosciences (AKYA) Target Price Reduced by Canaccord | AKYA Stock News - GuruFocus

May 19, 2025
pulisher
May 13, 2025

Akoya Biosciences (AKYA) Faces Uncertainty Amid Merger and Marke - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Akoya Biosciences, Inc. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 12, 2025

Akoya: Q1 Earnings Snapshot - The Washington Post

May 12, 2025
pulisher
May 12, 2025

Akoya Biosciences earnings missed by $0.11, revenue fell short of estimates - Investing.com Canada

May 12, 2025
pulisher
May 12, 2025

Akoya Biosciences (AKYA) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

Akoya Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

Akoya Biosciences Inc Reports Q1 2025 Earnings: EPS of -$0.18 Be - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Akoya Biosciences Reports First Quarter 2025 Financial Results - The Manila Times

May 12, 2025
pulisher
May 10, 2025

Akoya Biosciences (AKYA) Projected to Post Quarterly Earnings on Monday - Defense World

May 10, 2025
pulisher
May 07, 2025

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc.AKYA - Business Wire

May 07, 2025
pulisher
May 06, 2025

Akoya Biosciences, Inc. (NASDAQ:AKYA) Shares Acquired by JPMorgan Chase & Co. - Defense World

May 06, 2025
pulisher
May 05, 2025

Quanterix and Akoya Biosciences Announce Amended Merger Agreement - ADVFN

May 05, 2025
pulisher
May 05, 2025

Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance

May 05, 2025
pulisher
May 04, 2025

Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Average Recommendation of “Hold” by Analysts - Defense World

May 04, 2025
pulisher
May 01, 2025

Canaccord Genuity Group Has Lowered Expectations for Akoya Biosciences (NASDAQ:AKYA) Stock Price - Defense World

May 01, 2025
pulisher
Apr 30, 2025

AKYA Merger Faces Backlash Amid Shareholder Discontent | AKYA St - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Quanterix Acquisition of Akoya Biosciences (AKYA) Faces Challenges | AKYA Stock News - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Kent Lake Issues Statement on Quanterix?s Amendment to Merger with Akoya Biosciences - marketscreener.com

Apr 30, 2025
pulisher
Apr 29, 2025

Quanterix, Akoya Biosciences Amend Merger Deal - marketscreener.com

Apr 29, 2025
pulisher
Apr 29, 2025

Akoya stock falls on amended Quanterix merger deal (AKYA) - Seeking Alpha

Apr 29, 2025
pulisher
Apr 29, 2025

Quanterix Revises Merger Terms with Akoya Biosciences - TipRanks

Apr 29, 2025
pulisher
Apr 29, 2025

Merger Amendment: Changes to Quanterix and Akoya Biosciences (AK - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Quanterix And Akoya Biosciences Announce Amended Merger Agreement - marketscreener.com

Apr 29, 2025
pulisher
Apr 29, 2025

Canaccord Adjusts Price Target for Akoya Biosciences (AKYA) | AK - GuruFocus

Apr 29, 2025
pulisher
Apr 24, 2025

Akoya Biosciences introduces new assay for breast cancer ADC development By Investing.com - Investing.com South Africa

Apr 24, 2025

Finanzdaten der Akoya Biosciences Inc-Aktie (AKYA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$74.45
price down icon 0.03%
$184.91
price down icon 1.50%
medical_instruments_supplies COO
$70.08
price up icon 0.54%
$64.98
price down icon 0.17%
medical_instruments_supplies BAX
$30.47
price up icon 0.03%
medical_instruments_supplies WST
$218.15
price down icon 0.72%
Kapitalisierung:     |  Volumen (24h):